David believes that applying engineering principles to biology will be transformative for medicine. He is the original inventor of the DNA molecular counting platform at BillionToOne and has presented BillionToOne’s clinical trial results at national medical conferences. David has a bachelor’s degree in Physics, cum laude, from Princeton University with minors in Biophysics and Engineering Management Systems. While at Princeton, he was twice awarded the Shenstone Prize in Physics. He received a PhD in bioengineering from Rice University, where he was awarded a Nanobiology training fellowship.